For research use only. Not for therapeutic Use.
(+)-JQ1 PA (Cat.No:I019806) is a potent and selective bromodomain and extraterminal domain (BET) inhibitor. It acts by disrupting the binding of BET proteins to acetylated histones, leading to the suppression of gene transcription. (+)-JQ1 PA has shown promising anti-cancer activity in preclinical studies, making it a potential candidate for cancer therapy.
Catalog Number | I019806 |
CAS Number | 2115701-93-2 |
Molecular Formula | C₂₂H₂₀ClN₅OS |
Purity | ≥95% |
Target | Epigenetic Reader Domain |
Reference | [1]. Tyler DS, et al. Click chemistry enables preclinical evaluation of targeted epigenetic therapies. Science. 2017 Jun 30;356(6345):1397-1401. |